NCT05158049Enrolling by invitation
Longitudinal Study of a Bionic Eye
Longitudinal Observation and Assessment of the Suprachoroidal Retinal Prostheses
Source: ClinicalTrials.gov · Last updated 23 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a longitudinal observational study with participants who have been implanted with the suprachoroidal retinal prosthesis.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 7 (estimated)
- First submitted
- 2 Dec 2021
- Start date
- 9 Dec 2021
- Primary completion date
- 9 Dec 2026
- Lead sponsor
- Center for Eye Research Australia
- Diseases
- Retinitis pigmentosa
- NCT number
- NCT05158049
What you commit to
- Study type: Observational
- Planned participants: 7
- From 9 Dec 2021 to the primary completion date, 9 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Medical condition that prohibits mobility;
Other
- Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.
Who the study is looking for
- Willing to provide signed informed consent;
- Implanted with a suprachoroidal retinal prosthesis;
- Be available for the study visits;
- Willing to comply with study assessments;
- In good general health and mobile.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre for Eye Research Australia Coordinator of this site? Confirm its status | Melbourne E. | Australia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.